Myriad Genetics was founded in May 1991.
Our corporate headquarters and all our facilities are located at 320 Wakara Way, Salt Lake City, Utah
We completed our initial public offering in October 1995.
Our CUSIP number is 62855J104.
Our common stock is listed on the Nasdaq Global Select Market under the symbol “MYGN”.
You may purchase our stock through a registered stock broker, bank or through a financial institution that provides brokerage services. Myriad Genetics does not offer a direct purchase plan for investors.
Our calendar fiscal year ends on December 31.
• First quarter – March 31
• Second quarter – June 30
• Third quarter – September 30
• Fourth quarter – December 31
Our transfer agent is American Stock Transfer & Trust Company. They are responsible for maintaining all records of registered shareholders (including change of address and name), cancelling or issuing stock certificates and resolving problems related to lost, destroyed or stolen certificates. If your shares are held in Street name, you will have to contact your broker for these services. You may contact our transfer agent at:
American Stock Transfer & Trust Company
59 Maiden Lane
New York, New York 10038
If you have questions about your shareholder account you should contact our transfer agent, American Stock Transfer & Trust Company at (800) 937-5499. How do I contact Myriad Genetics’ investor relations department? Please contact Nathan Smith, Investor Relations, at: 801-505-5067 or email@example.com
Please contact Nathan Smith, Investor Relations, at: 801-505-5067 or firstname.lastname@example.org